On March 9, 2026, Item Second Irr. Trust FBO Kyle R. Westphal, a ten percent owner of Vertex, Inc., sold 10,000 shares of Class A Common Stock, while analysts reacted in mixed fashion to the company’s ...
If you are wondering whether Vertex Pharmaceuticals at around US$460 per share still lines up with its fundamentals, you are ...
Vertex Pharmaceuticals reported disappointing Q1 revenue and earnings. The company also revealed it is temporarily pausing part of a phase 1/2 study of experimental cystic fibrosis drug VX-522. Vertex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results